We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Thursday, April 10, 2025
Bayer is sticking to its legal strategy of trying individual Roundup cases in court, even as a series of recent losses has some investors and plaintiffs’ lawyers questioning the wisdom of that approach.
Bayer said it will appeal a jury verdict from a local court in Philadelphia awarding $175 million, including $150 million in punitive damages,to an 83-year-old city resident who claimed exposure to Roundup caused his cancer.